Dr. Reddy’s Faces GST Demand, Plans Appeal

Dr Reddy’s Laboratories (RDY) has released an update.

Dr. Reddy’s Laboratories Ltd. has been ordered by the GST authority to pay tax, interest, and penalties following the rejection of their appeal regarding credit availed in GST returns. The penalty levied amounts to Rs. 2,24,032, however, the company asserts that this will not materially impact their financial position or operations. They are considering filing an appeal against the order.

For further insights into RDY stock, check out TipRanks’ Stock Analysis page.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Tags

More Related Articles

Info icon

This data feed is not available at this time.

Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.